EBS Emergent BioSolutions Inc.

$6.23▲ +6.13% Healthcare Other
After hours $6.28▲ +0.80% Sep 11, 7:43 PM ET
Volume 1.30M Avg Volume (10D) 1.20M
Key Metrics & Fundamentals
Market Cap
$319.43M
P/E Ratio
–
Div Yield
–%
52W Range
4.36 - 14.06
% vs 50 MA
-4.09%
% vs 200 MA
-30.45%
RSI-14
54.4
MACD Histogram
+0.1100
Beta (1Y vs SPY)
1.16
Free Cash Flow
$54.00M
Gross Rev
$226.80M
Gross Profit
$129.70M
EBITDA
$90.20M
COGS
$97.10M
Operating Exp
$63.50M
Operating Income
$66.20M
EBIT
$66.20M
Pretax Income
-$166.30M
Net Income
-$180.20M
EPS (Diluted)
-3.49
Price & Volume History
Loading chart…
Recent News
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
GlobeNewswire · Sep 7, 2026 11:02 AM
Emergent BioSolutions Repurchases $75 Million of Senior Unsecured Notes Due 2028
MT Newswires · Sep 3, 2026 12:23 PM
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes
GlobeNewswire · Sep 3, 2026 11:45 AM
Emergent BioSolutions Wins $24 Million BARDA Contract for Anthrax Vaccine
MT Newswires · Sep 1, 2026 12:17 PM
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
GlobeNewswire · Sep 1, 2026 11:55 AM
Emergent BioSolutions Awarded Standing Offer for Narcan Nasal Spray in Canada
MT Newswires · Aug 31, 2026 12:22 PM
Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray
GlobeNewswire · Aug 31, 2026 11:55 AM
Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day
GlobeNewswire · Aug 31, 2026 11:54 AM
Emergent BioSolutions (EBS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 10:13 PM
Why Did TTD, PZZA, EBS Stocks Plummet To 52 Week Lows?
Stocktwits · Aug 11, 2026 4:02 AM
Financial Overview - Income Statement Quarterly

See EBS's money flow as a full page

Social Sentiment
Avg +0.42 · 6 posts
NewsTradeConnecticut's first case of clade I mpox + ANDV virus
r/stocks · May 14, 2026
The author anticipates a surge in EBS stock due to the mpox vaccine demand.
positive +0.80
DDTradeDiscussionHantavirus portfolio
r/stocks · May 8, 2026
The author believes EBS will perform well due to historical trends and a valuable 'national security' moat.
positive +0.70
DDPriceTargetA1 Releases September's 5 most undervalued stocks
r/wallstreetbets · Sep 2, 2024
Presented as an undervalued stock with potential upside.
positive +0.60
Sunk Cost Fallacy
r/stocks · Aug 26, 2024
The user is admitting to a significant loss on EBS and considering cutting losses, indicating negative sentiment.
negative -0.60
NewsDiscussionW.H.O. Declares Global Emergency Over New Mpox Outbreak
r/investing · Aug 14, 2024
Volatility is expected due to the news, suggesting potential upside for companies involved in vaccine production.
positive +0.60
Page 1 of 2 (6 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙